These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1790612)

  • 1. Fibrocystic condition and "at risk" lesions in asymptomatic breasts: a morphologic study of postmenopausal women.
    Sarnelli R; Squartini F
    Clin Exp Obstet Gynecol; 1991; 18(4):271-9. PubMed ID: 1790612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of the precancerous lesions in breasts contralateral to clinical cancer. A morphological comparison with breasts containing a benign lump.
    Sarnelli R; Squartini F
    Clin Exp Obstet Gynecol; 1993; 20(1):37-42. PubMed ID: 8462186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.
    Wellings SR; Jensen HM; Marcum RG
    J Natl Cancer Inst; 1975 Aug; 55(2):231-73. PubMed ID: 169369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of benign proliferative breast disease.
    Bodian CA; Perzin KH; Lattes R; Hoffmann P; Abernathy TG
    Cancer; 1993 Jun; 71(12):3896-907. PubMed ID: 8389654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microenvironment of human breast with clinical cancer.
    Sarnelli R; Squartini F
    Appl Pathol; 1983; 1(6):323-32. PubMed ID: 6679791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The histology of mastopathy and cumulative ipsilateral breast cancer sequence].
    Prechtel K; Gehm O; Geiger G; Prechtel P
    Pathologe; 1994 Jun; 15(3):158-64. PubMed ID: 8072949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study.
    Bartow SA; Pathak DR; Black WC; Key CR; Teaf SR
    Cancer; 1987 Dec; 60(11):2751-60. PubMed ID: 3677009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia.
    Pastides H; Kelsey JL; Holford TR; LiVolsi VA
    Am J Epidemiol; 1985 Mar; 121(3):440-7. PubMed ID: 4014134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is fibrocystic breast disease a pre-malignant state?
    Myhre E
    Acta Obstet Gynecol Scand Suppl; 1984; 123():189-91. PubMed ID: 6594011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign breast disease and the risk of breast cancer in the next 15 years.
    Socolov D; Anghelache I; Ilea C; Socolov R; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):135-40. PubMed ID: 25970956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphology of dysplasia and small cancer of the breast].
    Ermilova VD; Zolotarevskiĭ VB; Delektorskaia VV; Raĭkhlin NT
    Arkh Patol; 1985; 47(11):43-51. PubMed ID: 3004395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicators of increased breast cancer risk in humans.
    Page DL; Dupont WD
    J Cell Biochem Suppl; 1992; 16G():175-82. PubMed ID: 1469898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
    Masood S
    Womens Health (Lond); 2012 Jan; 8(1):57-62. PubMed ID: 22171775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis.
    Harvey JM; Sterrett GF; Frost FA
    Pathology; 2002 Oct; 34(5):410-6. PubMed ID: 12408338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.